United Guardian UG
NASDAQ UG
$7.19 +0.05 (+0.64%)
As of: Oct 1, 2026 · 3:24 PM EDT

United Guardian (UG) Income from Continuing Operations (2010 - 2026)

Updated

United Guardian's Income from Continuing Operations came in at $728,579 for Q2 2026, up 16.2% from $626,826 a year earlier but down 11.0% from the prior quarter.

Analysis

United Guardian (UG) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, United Guardian reported Income from Continuing Operations of $2.47 million, down 3.6% year-over-year; for FY2025, it was $2.11 million, down 35.2% from FY2024.

  • Income from Continuing Operations carries a five-year compound annual growth rate of -8.6% (FY2020 to FY2025).
  • Going back by year, Income from Continuing Operations was $3.25 million in FY2024 (+25.9%), $2.58 million in FY2023 (+0.5%), $2.57 million in FY2022 (-44.8%) and $4.66 million in FY2021 (+41.0%).
  • The five-year range for quarterly Income from Continuing Operations is $268,441 (Q3 2025) to $1.12 million (Q4 2021).
  • Year-over-year, Income from Continuing Operations has increased for three consecutive quarters, with an average decline of 5.7% over the last eight quarters.
  • The fastest year-over-year change in Income from Continuing Operations over five years came in Q2 2024 (growth of 107.4%), and the weakest in Q3 2025 (a decline of 69.0%).
  • Business Quant data shows UG's Income from Continuing Operations at $818,902 (Q1 2026), $649,576 (Q4 2025) and $268,441 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 5.53 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 3.62 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.28 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.09 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.50 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -246.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.10 Bn
10 United Guardian 32.90 Mn -1.61 Mn 1.55 Mn 728,579.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 728,579.00
Mar 31, 2026 818,902.00
Dec 31, 2025 649,576.00
Sep 30, 2025 268,441.00
Jun 30, 2025 626,826.00
Mar 31, 2025 560,895.00
Dec 31, 2024 503,724.00
Sep 30, 2024 865,484.00
Jun 30, 2024 956,225.00
Mar 31, 2024 925,442.00
Dec 31, 2023 737,439.00
Sep 30, 2023 626,756.00
Jun 30, 2023 461,094.00
Mar 31, 2023 756,081.00
Dec 31, 2022 679,205.00
Sep 30, 2022 345,518.00
Jun 30, 2022 633,324.00
Mar 31, 2022 911,465.00
Dec 31, 2021 1.12 Mn
Sep 30, 2021 1.02 Mn
API Access

United Guardian Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=UG&period=max&api_key=YOUR_API_KEY